Loading…
The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia
The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP). This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics...
Saved in:
Published in: | The American journal of emergency medicine 2020-09, Vol.38 (9), p.1796-1801 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123 |
---|---|
cites | cdi_FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123 |
container_end_page | 1801 |
container_issue | 9 |
container_start_page | 1796 |
container_title | The American journal of emergency medicine |
container_volume | 38 |
creator | Avci, Sema Perincek, Gokhan |
description | The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP).
This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups.
The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction.
A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED. |
doi_str_mv | 10.1016/j.ajem.2020.05.048 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2430095168</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735675720303958</els_id><sourcerecordid>2449741468</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMoOK7-AU8BLx7sNpXu9Ad4kcWPhQUv6znUJtWatrszVjIDg3_ejCMIHvZUUPW8Rb31CvESVA0KurdzjTOttVZa1crUqh0eiR2YRlcD9PBY7FTfmKrrTf9UPEtpVgqgNe1O_Lr7ThKXI8UFuULOxAEX-Y3RB9ryG7nf6LDGLaBMdCzDfJLJRaYkcfMybNOC64o58kmuyD-Ik8xR7pl8cFk2qvJYJpEzLmdt2P5tfC6eTLgkevG3XomvHz_cXX-ubr98url-f1u5poNcDS0BDj2OZMbBeNJag1Go7o0G7wZDE9yT6QhpGk1X-n0HnsZ-GBtPCnRzJV5f9u45_jxQynYNydGy4EbxkKxuG6VGA91Q0Ff_oXM88FauK1Q79i20fyh9oRzHlJgmu-dQ3J8sKHvOw872nIc952GVsSWPInp3EVGxegzENrnyYlcexeSy9TE8JP8NV6OVWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2449741468</pqid></control><display><type>article</type><title>The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Avci, Sema ; Perincek, Gokhan</creator><creatorcontrib>Avci, Sema ; Perincek, Gokhan</creatorcontrib><description>The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP).
This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups.
The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction.
A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED.</description><identifier>ISSN: 0735-6757</identifier><identifier>EISSN: 1532-8171</identifier><identifier>DOI: 10.1016/j.ajem.2020.05.048</identifier><language>eng</language><publisher>Philadelphia: Elsevier Inc</publisher><subject>Accuracy ; Albumin ; Alveolar-arterial oxygen gradient ; Alveoli ; Antibiotics ; Blood ; Blood platelets ; Cardiovascular disease ; Chronic illnesses ; Community-acquired pneumonia ; Creatinine ; Demography ; Emergency medical care ; Homeless people ; Independent sample ; Infections ; Inflammation ; Laboratories ; Lactic acid ; Medical prognosis ; Mortality ; Mortality risk ; Normal distribution ; Patients ; Phosphorus ; Pneumonia ; Procalcitonin ; Statistical analysis ; Survival ; Tuberculosis ; Uric acid</subject><ispartof>The American journal of emergency medicine, 2020-09, Vol.38 (9), p.1796-1801</ispartof><rights>2020 Elsevier Inc.</rights><rights>2020. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123</citedby><cites>FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Avci, Sema</creatorcontrib><creatorcontrib>Perincek, Gokhan</creatorcontrib><title>The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia</title><title>The American journal of emergency medicine</title><description>The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP).
This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups.
The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction.
A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED.</description><subject>Accuracy</subject><subject>Albumin</subject><subject>Alveolar-arterial oxygen gradient</subject><subject>Alveoli</subject><subject>Antibiotics</subject><subject>Blood</subject><subject>Blood platelets</subject><subject>Cardiovascular disease</subject><subject>Chronic illnesses</subject><subject>Community-acquired pneumonia</subject><subject>Creatinine</subject><subject>Demography</subject><subject>Emergency medical care</subject><subject>Homeless people</subject><subject>Independent sample</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Laboratories</subject><subject>Lactic acid</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Mortality risk</subject><subject>Normal distribution</subject><subject>Patients</subject><subject>Phosphorus</subject><subject>Pneumonia</subject><subject>Procalcitonin</subject><subject>Statistical analysis</subject><subject>Survival</subject><subject>Tuberculosis</subject><subject>Uric acid</subject><issn>0735-6757</issn><issn>1532-8171</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kU2LFDEQhoMoOK7-AU8BLx7sNpXu9Ad4kcWPhQUv6znUJtWatrszVjIDg3_ejCMIHvZUUPW8Rb31CvESVA0KurdzjTOttVZa1crUqh0eiR2YRlcD9PBY7FTfmKrrTf9UPEtpVgqgNe1O_Lr7ThKXI8UFuULOxAEX-Y3RB9ryG7nf6LDGLaBMdCzDfJLJRaYkcfMybNOC64o58kmuyD-Ik8xR7pl8cFk2qvJYJpEzLmdt2P5tfC6eTLgkevG3XomvHz_cXX-ubr98url-f1u5poNcDS0BDj2OZMbBeNJag1Go7o0G7wZDE9yT6QhpGk1X-n0HnsZ-GBtPCnRzJV5f9u45_jxQynYNydGy4EbxkKxuG6VGA91Q0Ff_oXM88FauK1Q79i20fyh9oRzHlJgmu-dQ3J8sKHvOw872nIc952GVsSWPInp3EVGxegzENrnyYlcexeSy9TE8JP8NV6OVWQ</recordid><startdate>202009</startdate><enddate>202009</enddate><creator>Avci, Sema</creator><creator>Perincek, Gokhan</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202009</creationdate><title>The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia</title><author>Avci, Sema ; Perincek, Gokhan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Accuracy</topic><topic>Albumin</topic><topic>Alveolar-arterial oxygen gradient</topic><topic>Alveoli</topic><topic>Antibiotics</topic><topic>Blood</topic><topic>Blood platelets</topic><topic>Cardiovascular disease</topic><topic>Chronic illnesses</topic><topic>Community-acquired pneumonia</topic><topic>Creatinine</topic><topic>Demography</topic><topic>Emergency medical care</topic><topic>Homeless people</topic><topic>Independent sample</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Laboratories</topic><topic>Lactic acid</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Mortality risk</topic><topic>Normal distribution</topic><topic>Patients</topic><topic>Phosphorus</topic><topic>Pneumonia</topic><topic>Procalcitonin</topic><topic>Statistical analysis</topic><topic>Survival</topic><topic>Tuberculosis</topic><topic>Uric acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Avci, Sema</creatorcontrib><creatorcontrib>Perincek, Gokhan</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Avci, Sema</au><au>Perincek, Gokhan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia</atitle><jtitle>The American journal of emergency medicine</jtitle><date>2020-09</date><risdate>2020</risdate><volume>38</volume><issue>9</issue><spage>1796</spage><epage>1801</epage><pages>1796-1801</pages><issn>0735-6757</issn><eissn>1532-8171</eissn><abstract>The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP).
This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups.
The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction.
A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED.</abstract><cop>Philadelphia</cop><pub>Elsevier Inc</pub><doi>10.1016/j.ajem.2020.05.048</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-6757 |
ispartof | The American journal of emergency medicine, 2020-09, Vol.38 (9), p.1796-1801 |
issn | 0735-6757 1532-8171 |
language | eng |
recordid | cdi_proquest_miscellaneous_2430095168 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Accuracy Albumin Alveolar-arterial oxygen gradient Alveoli Antibiotics Blood Blood platelets Cardiovascular disease Chronic illnesses Community-acquired pneumonia Creatinine Demography Emergency medical care Homeless people Independent sample Infections Inflammation Laboratories Lactic acid Medical prognosis Mortality Mortality risk Normal distribution Patients Phosphorus Pneumonia Procalcitonin Statistical analysis Survival Tuberculosis Uric acid |
title | The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A51%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20alveolar-arterial%20gradient,%20pneumonia%20severity%20scores%20and%20inflammatory%20markers%20to%20predict%2030-day%20mortality%20in%20pneumonia&rft.jtitle=The%20American%20journal%20of%20emergency%20medicine&rft.au=Avci,%20Sema&rft.date=2020-09&rft.volume=38&rft.issue=9&rft.spage=1796&rft.epage=1801&rft.pages=1796-1801&rft.issn=0735-6757&rft.eissn=1532-8171&rft_id=info:doi/10.1016/j.ajem.2020.05.048&rft_dat=%3Cproquest_cross%3E2449741468%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2449741468&rft_id=info:pmid/&rfr_iscdi=true |